Neurocrine Biosciences Inc (NBIX)
125.03
+1.74
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
123.15
-1.88
(-1.50%)
After-Hours: 20:00
Neurocrine Biosciences Price to Book Value: 4.656 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.591 |
| November 19, 2024 | 4.436 |
| November 18, 2024 | 4.38 |
| November 15, 2024 | 4.373 |
| November 14, 2024 | 4.576 |
| November 13, 2024 | 4.674 |
| November 12, 2024 | 4.730 |
| November 11, 2024 | 4.736 |
| November 08, 2024 | 4.682 |
| November 07, 2024 | 4.617 |
| November 06, 2024 | 4.666 |
| November 05, 2024 | 4.526 |
| November 04, 2024 | 4.488 |
| November 01, 2024 | 4.551 |
| October 31, 2024 | 4.479 |
| October 30, 2024 | 4.630 |
| October 29, 2024 | 4.327 |
| October 28, 2024 | 4.327 |
| October 25, 2024 | 4.323 |
| October 24, 2024 | 4.302 |
| October 23, 2024 | 4.283 |
| October 22, 2024 | 4.347 |
| October 21, 2024 | 4.339 |
| October 18, 2024 | 4.392 |
| October 17, 2024 | 4.409 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.405 |
| October 15, 2024 | 4.368 |
| October 14, 2024 | 4.334 |
| October 11, 2024 | 4.299 |
| October 10, 2024 | 4.184 |
| October 09, 2024 | 4.155 |
| October 08, 2024 | 4.156 |
| October 07, 2024 | 4.175 |
| October 04, 2024 | 4.243 |
| October 03, 2024 | 4.164 |
| October 02, 2024 | 4.241 |
| October 01, 2024 | 4.249 |
| September 30, 2024 | 4.289 |
| September 27, 2024 | 4.630 |
| September 26, 2024 | 4.665 |
| September 25, 2024 | 4.610 |
| September 24, 2024 | 4.688 |
| September 23, 2024 | 4.738 |
| September 20, 2024 | 4.763 |
| September 19, 2024 | 4.848 |
| September 18, 2024 | 4.823 |
| September 17, 2024 | 4.922 |
| September 16, 2024 | 4.920 |
| September 13, 2024 | 4.920 |
| September 12, 2024 | 4.881 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.155
Minimum
Oct 09 2024
19.01
Maximum
Dec 04 2019
7.954
Average
6.525
Median
Price to Book Value Benchmarks
| Repligen Corp | 3.937 |
| West Pharmaceutical Services Inc | 8.446 |
| Bruker Corp | 4.718 |
| The Cooper Companies Inc | 2.511 |
| Integra Lifesciences Holdings Corp | 1.166 |
Price to Book Value Related Metrics
| PE Ratio | 33.52 |
| PS Ratio | 5.770 |
| PEG Ratio | 0.3334 |
| Price to Free Cash Flow | 29.40 |
| Price | 125.03 |
| Earnings Yield | 2.98% |
| Market Cap | 12.66B |
| PEGY Ratio | 0.3334 |
| Operating PE Ratio | 22.00 |
| Normalized PE Ratio | 39.52 |